This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2019. "We're...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that...
The rate of workforce drug positivity hit a fourteen-year high in 2018, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence awards to four companies at its 2019 Supplier Forum. Supplier...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory in...